Cargando…
From HIV to COVID-19, Molecular mechanisms of pathogens’ trade-off and persistence in the community, potential targets for new drug development
BACKGROUND: On the staggering emergence of the Omicron variant, numerous questions arose about the evolution of virulence and transmissibility in microbes. MAIN BODY OF THE ABSTRACT: The trade-off hypothesis has long speculated the exchange of virulence for the sake of superior transmissibility in a...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258762/ https://www.ncbi.nlm.nih.gov/pubmed/35818410 http://dx.doi.org/10.1186/s42269-022-00879-w |
_version_ | 1784741619406209024 |
---|---|
author | AbdelMassih, Antoine Sedky, Abrar Shalaby, Ahmed Shalaby, AlAmira-Fawzia Yasser, Alia Mohyeldin, Aya Amin, Basma Saleheen, Basma Osman, Dina Samuel, Elaria Abdelfatah, Emmy Albustami, Eveen ElGhamry, Farida Khaled, Habiba Amr, Hana Gaber, Hanya Makhlouf, Ismail Abdeldayem, Janna El-Beialy, Jana Waleed Milad, Karim El Sharkawi, Laila Abosenna, Lina Safi, Madonna G. AbdelKareem, Mariam Gaber, Marwa Elkady, Mirna Ihab, Mohamed AbdelRaouf, Nora Khaled, Rawan Shalata, Reem Mahgoub, Rudayna Jamal, Sarah El Hawary, Seif El-Din ElRashidy, Shady El Shorbagy, Sherouk Gerges, Tony Kassem, Yara Magdy, Yasmeen Omar, Yasmin Shokry, Yasmine Kamel, Aya Hozaien, Rafeef El-Husseiny, Nadine El Shershaby, Meryam |
author_facet | AbdelMassih, Antoine Sedky, Abrar Shalaby, Ahmed Shalaby, AlAmira-Fawzia Yasser, Alia Mohyeldin, Aya Amin, Basma Saleheen, Basma Osman, Dina Samuel, Elaria Abdelfatah, Emmy Albustami, Eveen ElGhamry, Farida Khaled, Habiba Amr, Hana Gaber, Hanya Makhlouf, Ismail Abdeldayem, Janna El-Beialy, Jana Waleed Milad, Karim El Sharkawi, Laila Abosenna, Lina Safi, Madonna G. AbdelKareem, Mariam Gaber, Marwa Elkady, Mirna Ihab, Mohamed AbdelRaouf, Nora Khaled, Rawan Shalata, Reem Mahgoub, Rudayna Jamal, Sarah El Hawary, Seif El-Din ElRashidy, Shady El Shorbagy, Sherouk Gerges, Tony Kassem, Yara Magdy, Yasmeen Omar, Yasmin Shokry, Yasmine Kamel, Aya Hozaien, Rafeef El-Husseiny, Nadine El Shershaby, Meryam |
author_sort | AbdelMassih, Antoine |
collection | PubMed |
description | BACKGROUND: On the staggering emergence of the Omicron variant, numerous questions arose about the evolution of virulence and transmissibility in microbes. MAIN BODY OF THE ABSTRACT: The trade-off hypothesis has long speculated the exchange of virulence for the sake of superior transmissibility in a wide array of pathogens. While this certainly applies to the case of the Omicron variant, along with influenza virus, various reports have been allocated for an array of pathogens such as human immunodeficiency virus (HIV), malaria, hepatitis B virus (HBV) and tuberculosis (TB). The latter abide to another form of trade-off, the invasion–persistence trade-off. In this study, we aim to explore the molecular mechanisms and mutations of different obligate intracellular pathogens that attenuated their more morbid characters, virulence in acute infections and invasion in chronic infections. SHORT CONCLUSION: Recognizing the mutations that attenuate the most morbid characters of pathogens such as virulence or persistence can help in tailoring new therapies for such pathogens. Targeting macrophage tropism of HIV by carbohydrate-binding agents, or targeting the TMPRSS2 receptors to prevent pulmonary infiltrates of COVID-19 is an example of how important is to recognize such genetic mechanisms. |
format | Online Article Text |
id | pubmed-9258762 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-92587622022-07-07 From HIV to COVID-19, Molecular mechanisms of pathogens’ trade-off and persistence in the community, potential targets for new drug development AbdelMassih, Antoine Sedky, Abrar Shalaby, Ahmed Shalaby, AlAmira-Fawzia Yasser, Alia Mohyeldin, Aya Amin, Basma Saleheen, Basma Osman, Dina Samuel, Elaria Abdelfatah, Emmy Albustami, Eveen ElGhamry, Farida Khaled, Habiba Amr, Hana Gaber, Hanya Makhlouf, Ismail Abdeldayem, Janna El-Beialy, Jana Waleed Milad, Karim El Sharkawi, Laila Abosenna, Lina Safi, Madonna G. AbdelKareem, Mariam Gaber, Marwa Elkady, Mirna Ihab, Mohamed AbdelRaouf, Nora Khaled, Rawan Shalata, Reem Mahgoub, Rudayna Jamal, Sarah El Hawary, Seif El-Din ElRashidy, Shady El Shorbagy, Sherouk Gerges, Tony Kassem, Yara Magdy, Yasmeen Omar, Yasmin Shokry, Yasmine Kamel, Aya Hozaien, Rafeef El-Husseiny, Nadine El Shershaby, Meryam Bull Natl Res Cent Review BACKGROUND: On the staggering emergence of the Omicron variant, numerous questions arose about the evolution of virulence and transmissibility in microbes. MAIN BODY OF THE ABSTRACT: The trade-off hypothesis has long speculated the exchange of virulence for the sake of superior transmissibility in a wide array of pathogens. While this certainly applies to the case of the Omicron variant, along with influenza virus, various reports have been allocated for an array of pathogens such as human immunodeficiency virus (HIV), malaria, hepatitis B virus (HBV) and tuberculosis (TB). The latter abide to another form of trade-off, the invasion–persistence trade-off. In this study, we aim to explore the molecular mechanisms and mutations of different obligate intracellular pathogens that attenuated their more morbid characters, virulence in acute infections and invasion in chronic infections. SHORT CONCLUSION: Recognizing the mutations that attenuate the most morbid characters of pathogens such as virulence or persistence can help in tailoring new therapies for such pathogens. Targeting macrophage tropism of HIV by carbohydrate-binding agents, or targeting the TMPRSS2 receptors to prevent pulmonary infiltrates of COVID-19 is an example of how important is to recognize such genetic mechanisms. Springer Berlin Heidelberg 2022-07-06 2022 /pmc/articles/PMC9258762/ /pubmed/35818410 http://dx.doi.org/10.1186/s42269-022-00879-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Review AbdelMassih, Antoine Sedky, Abrar Shalaby, Ahmed Shalaby, AlAmira-Fawzia Yasser, Alia Mohyeldin, Aya Amin, Basma Saleheen, Basma Osman, Dina Samuel, Elaria Abdelfatah, Emmy Albustami, Eveen ElGhamry, Farida Khaled, Habiba Amr, Hana Gaber, Hanya Makhlouf, Ismail Abdeldayem, Janna El-Beialy, Jana Waleed Milad, Karim El Sharkawi, Laila Abosenna, Lina Safi, Madonna G. AbdelKareem, Mariam Gaber, Marwa Elkady, Mirna Ihab, Mohamed AbdelRaouf, Nora Khaled, Rawan Shalata, Reem Mahgoub, Rudayna Jamal, Sarah El Hawary, Seif El-Din ElRashidy, Shady El Shorbagy, Sherouk Gerges, Tony Kassem, Yara Magdy, Yasmeen Omar, Yasmin Shokry, Yasmine Kamel, Aya Hozaien, Rafeef El-Husseiny, Nadine El Shershaby, Meryam From HIV to COVID-19, Molecular mechanisms of pathogens’ trade-off and persistence in the community, potential targets for new drug development |
title | From HIV to COVID-19, Molecular mechanisms of pathogens’ trade-off and persistence in the community, potential targets for new drug development |
title_full | From HIV to COVID-19, Molecular mechanisms of pathogens’ trade-off and persistence in the community, potential targets for new drug development |
title_fullStr | From HIV to COVID-19, Molecular mechanisms of pathogens’ trade-off and persistence in the community, potential targets for new drug development |
title_full_unstemmed | From HIV to COVID-19, Molecular mechanisms of pathogens’ trade-off and persistence in the community, potential targets for new drug development |
title_short | From HIV to COVID-19, Molecular mechanisms of pathogens’ trade-off and persistence in the community, potential targets for new drug development |
title_sort | from hiv to covid-19, molecular mechanisms of pathogens’ trade-off and persistence in the community, potential targets for new drug development |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258762/ https://www.ncbi.nlm.nih.gov/pubmed/35818410 http://dx.doi.org/10.1186/s42269-022-00879-w |
work_keys_str_mv | AT abdelmassihantoine fromhivtocovid19molecularmechanismsofpathogenstradeoffandpersistenceinthecommunitypotentialtargetsfornewdrugdevelopment AT sedkyabrar fromhivtocovid19molecularmechanismsofpathogenstradeoffandpersistenceinthecommunitypotentialtargetsfornewdrugdevelopment AT shalabyahmed fromhivtocovid19molecularmechanismsofpathogenstradeoffandpersistenceinthecommunitypotentialtargetsfornewdrugdevelopment AT shalabyalamirafawzia fromhivtocovid19molecularmechanismsofpathogenstradeoffandpersistenceinthecommunitypotentialtargetsfornewdrugdevelopment AT yasseralia fromhivtocovid19molecularmechanismsofpathogenstradeoffandpersistenceinthecommunitypotentialtargetsfornewdrugdevelopment AT mohyeldinaya fromhivtocovid19molecularmechanismsofpathogenstradeoffandpersistenceinthecommunitypotentialtargetsfornewdrugdevelopment AT aminbasma fromhivtocovid19molecularmechanismsofpathogenstradeoffandpersistenceinthecommunitypotentialtargetsfornewdrugdevelopment AT saleheenbasma fromhivtocovid19molecularmechanismsofpathogenstradeoffandpersistenceinthecommunitypotentialtargetsfornewdrugdevelopment AT osmandina fromhivtocovid19molecularmechanismsofpathogenstradeoffandpersistenceinthecommunitypotentialtargetsfornewdrugdevelopment AT samuelelaria fromhivtocovid19molecularmechanismsofpathogenstradeoffandpersistenceinthecommunitypotentialtargetsfornewdrugdevelopment AT abdelfatahemmy fromhivtocovid19molecularmechanismsofpathogenstradeoffandpersistenceinthecommunitypotentialtargetsfornewdrugdevelopment AT albustamieveen fromhivtocovid19molecularmechanismsofpathogenstradeoffandpersistenceinthecommunitypotentialtargetsfornewdrugdevelopment AT elghamryfarida fromhivtocovid19molecularmechanismsofpathogenstradeoffandpersistenceinthecommunitypotentialtargetsfornewdrugdevelopment AT khaledhabiba fromhivtocovid19molecularmechanismsofpathogenstradeoffandpersistenceinthecommunitypotentialtargetsfornewdrugdevelopment AT amrhana fromhivtocovid19molecularmechanismsofpathogenstradeoffandpersistenceinthecommunitypotentialtargetsfornewdrugdevelopment AT gaberhanya fromhivtocovid19molecularmechanismsofpathogenstradeoffandpersistenceinthecommunitypotentialtargetsfornewdrugdevelopment AT makhloufismail fromhivtocovid19molecularmechanismsofpathogenstradeoffandpersistenceinthecommunitypotentialtargetsfornewdrugdevelopment AT abdeldayemjanna fromhivtocovid19molecularmechanismsofpathogenstradeoffandpersistenceinthecommunitypotentialtargetsfornewdrugdevelopment AT elbeialyjanawaleed fromhivtocovid19molecularmechanismsofpathogenstradeoffandpersistenceinthecommunitypotentialtargetsfornewdrugdevelopment AT miladkarim fromhivtocovid19molecularmechanismsofpathogenstradeoffandpersistenceinthecommunitypotentialtargetsfornewdrugdevelopment AT elsharkawilaila fromhivtocovid19molecularmechanismsofpathogenstradeoffandpersistenceinthecommunitypotentialtargetsfornewdrugdevelopment AT abosennalina fromhivtocovid19molecularmechanismsofpathogenstradeoffandpersistenceinthecommunitypotentialtargetsfornewdrugdevelopment AT safimadonnag fromhivtocovid19molecularmechanismsofpathogenstradeoffandpersistenceinthecommunitypotentialtargetsfornewdrugdevelopment AT abdelkareemmariam fromhivtocovid19molecularmechanismsofpathogenstradeoffandpersistenceinthecommunitypotentialtargetsfornewdrugdevelopment AT gabermarwa fromhivtocovid19molecularmechanismsofpathogenstradeoffandpersistenceinthecommunitypotentialtargetsfornewdrugdevelopment AT elkadymirna fromhivtocovid19molecularmechanismsofpathogenstradeoffandpersistenceinthecommunitypotentialtargetsfornewdrugdevelopment AT ihabmohamed fromhivtocovid19molecularmechanismsofpathogenstradeoffandpersistenceinthecommunitypotentialtargetsfornewdrugdevelopment AT abdelraoufnora fromhivtocovid19molecularmechanismsofpathogenstradeoffandpersistenceinthecommunitypotentialtargetsfornewdrugdevelopment AT khaledrawan fromhivtocovid19molecularmechanismsofpathogenstradeoffandpersistenceinthecommunitypotentialtargetsfornewdrugdevelopment AT shalatareem fromhivtocovid19molecularmechanismsofpathogenstradeoffandpersistenceinthecommunitypotentialtargetsfornewdrugdevelopment AT mahgoubrudayna fromhivtocovid19molecularmechanismsofpathogenstradeoffandpersistenceinthecommunitypotentialtargetsfornewdrugdevelopment AT jamalsarah fromhivtocovid19molecularmechanismsofpathogenstradeoffandpersistenceinthecommunitypotentialtargetsfornewdrugdevelopment AT elhawaryseifeldin fromhivtocovid19molecularmechanismsofpathogenstradeoffandpersistenceinthecommunitypotentialtargetsfornewdrugdevelopment AT elrashidyshady fromhivtocovid19molecularmechanismsofpathogenstradeoffandpersistenceinthecommunitypotentialtargetsfornewdrugdevelopment AT elshorbagysherouk fromhivtocovid19molecularmechanismsofpathogenstradeoffandpersistenceinthecommunitypotentialtargetsfornewdrugdevelopment AT gergestony fromhivtocovid19molecularmechanismsofpathogenstradeoffandpersistenceinthecommunitypotentialtargetsfornewdrugdevelopment AT kassemyara fromhivtocovid19molecularmechanismsofpathogenstradeoffandpersistenceinthecommunitypotentialtargetsfornewdrugdevelopment AT magdyyasmeen fromhivtocovid19molecularmechanismsofpathogenstradeoffandpersistenceinthecommunitypotentialtargetsfornewdrugdevelopment AT omaryasmin fromhivtocovid19molecularmechanismsofpathogenstradeoffandpersistenceinthecommunitypotentialtargetsfornewdrugdevelopment AT shokryyasmine fromhivtocovid19molecularmechanismsofpathogenstradeoffandpersistenceinthecommunitypotentialtargetsfornewdrugdevelopment AT kamelaya fromhivtocovid19molecularmechanismsofpathogenstradeoffandpersistenceinthecommunitypotentialtargetsfornewdrugdevelopment AT hozaienrafeef fromhivtocovid19molecularmechanismsofpathogenstradeoffandpersistenceinthecommunitypotentialtargetsfornewdrugdevelopment AT elhusseinynadine fromhivtocovid19molecularmechanismsofpathogenstradeoffandpersistenceinthecommunitypotentialtargetsfornewdrugdevelopment AT elshershabymeryam fromhivtocovid19molecularmechanismsofpathogenstradeoffandpersistenceinthecommunitypotentialtargetsfornewdrugdevelopment |